Treatment of Lyme Disease
Doxycycline 100 mg twice daily for 10-21 days is the first-line treatment for early Lyme disease in non-pregnant adults and children ≥8 years old. 1, 2
First-Line Oral Antibiotic Regimens
Adults
- Doxycycline 100 mg orally twice daily for 10-21 days (preferred agent) 1, 2
- Amoxicillin 500 mg orally three times daily for 14-21 days (alternative, especially for pregnant women and children <8 years) 1, 2
- Cefuroxime axetil 500 mg orally twice daily for 14-21 days (second alternative) 1, 2
Children ≥8 Years
Children <8 Years
- Amoxicillin 50 mg/kg/day in 3 divided doses (maximum 500 mg per dose) for 14 days (preferred) 2, 3
- Cefuroxime axetil 30 mg/kg/day in 2 divided doses (maximum 500 mg per dose) for 14 days (alternative) 2, 3
Pregnant Women
- Amoxicillin 500 mg orally three times daily for 14-21 days 1, 4
- Doxycycline is contraindicated due to risk of permanent tooth discoloration and bone formation effects in the fetus 4
Parenteral Therapy for Neurological or Cardiac Involvement
Intravenous ceftriaxone 2 g once daily for 14-28 days is the preferred treatment for neurological manifestations (meningitis, radiculopathy, cranial nerve palsy with other symptoms). 1, 3
Alternative Parenteral Options
- Cefotaxime 2 g IV every 8 hours 1
- Penicillin G 18-24 million units per day IV divided every 4 hours 1
Pediatric Parenteral Dosing
- Ceftriaxone 50-75 mg/kg/day IV (maximum 2 g daily) for neurological involvement or carditis with advanced heart block 3
Special Case: Isolated Facial Nerve Palsy
- If the patient has isolated seventh cranial nerve palsy with no other symptoms and normal cerebrospinal fluid, oral therapy is sufficient 5
Treatment Duration Considerations
The duration varies based on antibiotic choice and disease stage:
- Doxycycline: 10 days is sufficient for early Lyme disease 2, 3
- β-lactam antibiotics (amoxicillin, cefuroxime): 14 days minimum due to shorter half-life 3
- Neurological involvement: 14-28 days of IV therapy 1
Management of Lyme Arthritis
- Initial treatment: oral antibiotics as above for 14-21 days 1
- If no or minimal response: IV ceftriaxone 2 g daily for 2-4 weeks 1
- Consider other causes of joint swelling if partial response occurs 1
Co-infection Considerations
If human granulocytic anaplasmosis (HGA) is suspected or confirmed, doxycycline 100 mg twice daily for 10 days treats both infections simultaneously. 5
Alternative for HGA in Patients Who Cannot Take Doxycycline
- Rifampin 300 mg twice daily for 7-10 days (adults) or 10 mg/kg twice daily (children, maximum 300 mg per dose) 5
- Must add amoxicillin or cefuroxime axetil at standard Lyme disease doses since rifampin does not treat Borrelia burgdorferi 5
Babesiosis Co-infection
- All patients with active babesiosis require antimicrobial treatment due to risk of complications 5
- Partial or complete RBC exchange transfusion is indicated for high-grade parasitemia (≥10%), significant hemolysis, or organ compromise 5
Critical Pitfalls to Avoid
Ineffective Antibiotics (Never Use)
- First-generation cephalosporins (e.g., cephalexin) are completely inactive against B. burgdorferi 1, 2, 3
- Fluoroquinolones, carbapenems, vancomycin, metronidazole, tinidazole are ineffective 1
Suboptimal Antibiotics (Use Only When Necessary)
- Macrolides (azithromycin, clarithromycin, erythromycin) are significantly less effective than first-line agents and should only be used when patients cannot tolerate doxycycline, amoxicillin, or cefuroxime 1, 2, 3
- Patients on macrolides require close observation to ensure resolution 3
Inappropriate Treatment Approaches
- Long-term antibiotic therapy beyond recommended durations is strongly contraindicated due to lack of efficacy and potential for harm 1
- Combination antibiotic therapy, pulsed-dosing, and other unproven approaches should not be used 1
- Extending treatment beyond 21 days for early Lyme disease is not supported by evidence 2
Doxycycline Administration Considerations
- Take with 8 ounces of fluid to reduce esophageal irritation 2, 3
- Take with food to minimize gastrointestinal intolerance 2, 3
- Avoid sun exposure due to photosensitivity risk 2, 3
Post-Treatment Monitoring
Serologic tests remain positive for months to years after successful treatment and should not be used to monitor treatment response or determine cure. 1
When Clinical Improvement Is Expected
- Most patients respond promptly and completely to appropriate antibiotic therapy 3
- Clinical improvement within 48 hours for mild-to-moderate disease 5
- Symptoms should completely resolve within 3 months for babesiosis co-infection 5
- Late neurologic manifestations respond slowly and may be incomplete 1
When to Consider Treatment Failure or Reinfection
- Persistent objective signs (arthritis, meningitis, neuropathy) may indicate treatment failure 1
- New erythema migrans lesions or new objective manifestations after previous successful treatment suggest reinfection 1
- Persistent fever or characteristic laboratory abnormalities warrant evaluation for co-infections 1